世界のイリノテカン塩酸塩API産業:成長傾向・競合分析2019-2025

QYResearchが発行した調査報告書(QYR20FB05594)
◆英語タイトル:Global Irinotecan Hydrochloride API Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
◆商品コード:QYR20FB05594
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年10月30日(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD8,400 ⇒換算¥1,243,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界のイリノテカン塩酸塩API市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。イリノテカン塩酸塩APIの種類別には、純度≥98%、純度≥99%に、用途別には、イリノテカン塩酸塩経口、イリノテカン塩酸塩注射に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・イリノテカン塩酸塩APIの種類別市場規模:純度≥98%、純度≥99%
・イリノテカン塩酸塩APIの用途別市場規模:イリノテカン塩酸塩経口、イリノテカン塩酸塩注射
・イリノテカン塩酸塩APIの地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Scion Pharm Taiwan、Acebright、Sai Phytoceuticals、Hubei Haosun Pharmaceutical、Arch Pharmalabs、Avra Laboratories、Cipla、Lianyungang Jari Pharmaceutical、Qilu Pharmaceutial、Sichuan Xieli Pharmaceutical
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

It has the function of anti – tumor and anti – cell mitosis. The molecular formula is C33H39ClN4O6, and CAS number is 100286-90-6.The Irinotecan Hydrochloride API market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Irinotecan Hydrochloride API.

This study focuses on the production side and consumption side of Irinotecan Hydrochloride API, presents the global Irinotecan Hydrochloride API market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
In terms of production side, this report researches the Irinotecan Hydrochloride API capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Irinotecan Hydrochloride API by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.
Scion Pharm Taiwan
Acebright
Sai Phytoceuticals
Hubei Haosun Pharmaceutical
Arch Pharmalabs
Avra Laboratories
Cipla
Lianyungang Jari Pharmaceutical
Qilu Pharmaceutial
Sichuan Xieli Pharmaceutical

Market Segment by Product Type
Purity ≥ 98 %
Purity ≥ 99 %

Market Segment by Application
Irinotecan Hydrochloride Oral
Irinotecan Hydrochloride Injection

Key Regions split in this report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Irinotecan Hydrochloride API status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Irinotecan Hydrochloride API manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Irinotecan Hydrochloride API are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Irinotecan Hydrochloride API Market Size Growth Rate by Type
1.3.2 Purity ≥ 98 %
1.3.3 Purity ≥ 99 %
1.4 Market Segment by Application
1.4.1 Global Irinotecan Hydrochloride API Market Share by Application (2019-2025)
1.4.2 Irinotecan Hydrochloride Oral
1.4.3 Irinotecan Hydrochloride Injection
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Irinotecan Hydrochloride API Production Value 2014-2025
2.1.2 Global Irinotecan Hydrochloride API Production 2014-2025
2.1.3 Global Irinotecan Hydrochloride API Capacity 2014-2025
2.1.4 Global Irinotecan Hydrochloride API Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Irinotecan Hydrochloride API Market Size CAGR of Key Regions
2.2.2 Global Irinotecan Hydrochloride API Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Irinotecan Hydrochloride API Capacity by Manufacturers
3.1.2 Global Irinotecan Hydrochloride API Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Irinotecan Hydrochloride API Revenue by Manufacturers (2014-2019)
3.2.2 Irinotecan Hydrochloride API Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Irinotecan Hydrochloride API Market Concentration Ratio (CR5 and HHI)
3.3 Irinotecan Hydrochloride API Price by Manufacturers
3.4 Key Manufacturers Irinotecan Hydrochloride API Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Irinotecan Hydrochloride API Market
3.6 Key Manufacturers Irinotecan Hydrochloride API Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Purity ≥ 98 % Production and Production Value (2014-2019)
4.1.2 Purity ≥ 99 % Production and Production Value (2014-2019)
4.2 Global Irinotecan Hydrochloride API Production Market Share by Type
4.3 Global Irinotecan Hydrochloride API Production Value Market Share by Type
4.4 Irinotecan Hydrochloride API Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Irinotecan Hydrochloride API Consumption by Application

6 Production by Regions
6.1 Global Irinotecan Hydrochloride API Production (History Data) by Regions 2014-2019
6.2 Global Irinotecan Hydrochloride API Production Value (History Data) by Regions
6.3 North America
6.3.1 North AmericaIrinotecan Hydrochloride API Production Growth Rate 2014-2019
6.3.2 North America Irinotecan Hydrochloride API Production Value Growth Rate 2014-2019
6.3.3 Key Players in North America
6.3.4 North America Irinotecan Hydrochloride API Import & Export
6.4 Europe
6.4.1 Europe Irinotecan Hydrochloride API Production Growth Rate 2014-2019
6.4.2 Europe Irinotecan Hydrochloride API Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Irinotecan Hydrochloride API Import & Export
6.5 China
6.5.1 China Irinotecan Hydrochloride API Production Growth Rate 2014-2019
6.5.2 China Irinotecan Hydrochloride API Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Irinotecan Hydrochloride API Import & Export
6.6 Japan
6.6.1 Japan Irinotecan Hydrochloride API Production Growth Rate 2014-2019
6.6.2 Japan Irinotecan Hydrochloride API Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Irinotecan Hydrochloride API Import & Export

7 Irinotecan Hydrochloride API Consumption by Regions
7.1 Global Irinotecan Hydrochloride API Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Irinotecan Hydrochloride API Consumption by Type
7.2.2 North America Irinotecan Hydrochloride API Consumption by Application
7.2.3 North America Irinotecan Hydrochloride API Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Irinotecan Hydrochloride API Consumption by Type
7.3.2 Europe Irinotecan Hydrochloride API Consumption by Application
7.3.3 Europe Irinotecan Hydrochloride API Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Irinotecan Hydrochloride API Consumption by Type
7.4.2 Asia Pacific Irinotecan Hydrochloride API Consumption by Application
7.4.3 Asia Pacific Irinotecan Hydrochloride API Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Irinotecan Hydrochloride API Consumption by Type
7.5.2 Central & South America Irinotecan Hydrochloride API Consumption by Application
7.5.3 Central & South America Irinotecan Hydrochloride API Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Irinotecan Hydrochloride API Consumption by Type
7.6.2 Middle East and Africa Irinotecan Hydrochloride API Consumption by Application
7.6.3 Central & South America Irinotecan Hydrochloride API Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa

8 Company Profiles
8.1 Scion Pharm Taiwan
8.1.1 Scion Pharm Taiwan Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Irinotecan Hydrochloride API
8.1.4 Irinotecan Hydrochloride API Product Introduction
8.1.5 Scion Pharm Taiwan Recent Development
8.2 Acebright
8.2.1 Acebright Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Irinotecan Hydrochloride API
8.2.4 Irinotecan Hydrochloride API Product Introduction
8.2.5 Acebright Recent Development
8.3 Sai Phytoceuticals
8.3.1 Sai Phytoceuticals Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Irinotecan Hydrochloride API
8.3.4 Irinotecan Hydrochloride API Product Introduction
8.3.5 Sai Phytoceuticals Recent Development
8.4 Hubei Haosun Pharmaceutical
8.4.1 Hubei Haosun Pharmaceutical Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Irinotecan Hydrochloride API
8.4.4 Irinotecan Hydrochloride API Product Introduction
8.4.5 Hubei Haosun Pharmaceutical Recent Development
8.5 Arch Pharmalabs
8.5.1 Arch Pharmalabs Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Irinotecan Hydrochloride API
8.5.4 Irinotecan Hydrochloride API Product Introduction
8.5.5 Arch Pharmalabs Recent Development
8.6 Avra Laboratories
8.6.1 Avra Laboratories Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Irinotecan Hydrochloride API
8.6.4 Irinotecan Hydrochloride API Product Introduction
8.6.5 Avra Laboratories Recent Development
8.7 Cipla
8.7.1 Cipla Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Irinotecan Hydrochloride API
8.7.4 Irinotecan Hydrochloride API Product Introduction
8.7.5 Cipla Recent Development
8.8 Lianyungang Jari Pharmaceutical
8.8.1 Lianyungang Jari Pharmaceutical Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Irinotecan Hydrochloride API
8.8.4 Irinotecan Hydrochloride API Product Introduction
8.8.5 Lianyungang Jari Pharmaceutical Recent Development
8.9 Qilu Pharmaceutial
8.9.1 Qilu Pharmaceutial Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Irinotecan Hydrochloride API
8.9.4 Irinotecan Hydrochloride API Product Introduction
8.9.5 Qilu Pharmaceutial Recent Development
8.10 Sichuan Xieli Pharmaceutical
8.10.1 Sichuan Xieli Pharmaceutical Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Irinotecan Hydrochloride API
8.10.4 Irinotecan Hydrochloride API Product Introduction
8.10.5 Sichuan Xieli Pharmaceutical Recent Development

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Irinotecan Hydrochloride API Capacity, Production Forecast 2019-2025
9.1.2 Global Irinotecan Hydrochloride API Production Value Forecast 2019-2025
9.2 Irinotecan Hydrochloride API Production and Production Value Forecast by Regions
9.2.1 Global Irinotecan Hydrochloride API Production Value Forecast by Regions
9.2.2 Global Irinotecan Hydrochloride API Production Forecast by Regions
9.3 Irinotecan Hydrochloride API Key Producers Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Irinotecan Hydrochloride API Production Forecast by Type
9.4.2 Global Irinotecan Hydrochloride API Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Irinotecan Hydrochloride API Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Irinotecan Hydrochloride API Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Irinotecan Hydrochloride API Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Irinotecan Hydrochloride API Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Irinotecan Hydrochloride API Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Irinotecan Hydrochloride API Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Irinotecan Hydrochloride API Sales Channels
11.2.2 Irinotecan Hydrochloride API Distributors
11.3 Irinotecan Hydrochloride API Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

...

【掲載企業】

Scion Pharm Taiwan、Acebright、Sai Phytoceuticals、Hubei Haosun Pharmaceutical、Arch Pharmalabs、Avra Laboratories、Cipla、Lianyungang Jari Pharmaceutical、Qilu Pharmaceutial、Sichuan Xieli Pharmaceutical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のイリノテカン塩酸塩API産業:成長傾向・競合分析2019-2025(Global Irinotecan Hydrochloride API Industry Research Report, Growth Trends and Competitive Analysis 2019-2025)]についてメールでお問い合わせはこちらでお願いします。